FDA approves Caplyta for major depressive disorder in adults

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...
STAT

FDA approves J&J’s antipsychotic drug to treat depression

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...
MedPage Today on MSN

FDA Broadens Caplyta Approval to Include Major Depression

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...
Medscape

FDA Clears Accelerated TMS Protocol for Major Depression

The FDA has expanded clearance for an accelerated treatment protocol for the noninvasive Deep Transcranial Magnetic Stimulation (Deep TMS, BrainsWay) system for depressive episodes and anxiety ...
Medicine Buffalo

How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...